February 27, 2020 / 7:14 AM / a month ago

BRIEF-Arjo Starts Randomized Controlled Trial For Wound Care Treatment

Feb 27 (Reuters) - Arjo AB (publ):

* ARJO INITIATES A RANDOMIZED CONTROLLED TRIAL FOR WOUND CARE TREATMENT AFTER STRONG EVALUATION RESULTS

* WILL TODAY PUBLISH RESULTS FROM A HIGHLY SUCCESSFUL MULTI-CENTRE CLINICAL EVALUATION FOR RECENTLY LAUNCHED WOUNDEXPRESS™

* EVALUATION IS SHOWING HIGHLY PROMISING RESULTS

* IN OVER 95% OF CASES, SIGNIFICANT IMPROVEMENT WAS SEEN IN WOUND HEALING AND IN A THIRD OF CASES, WOUNDS HEALED ENTIRELY.

* FURTHER, OVER 95% OF PATIENTS REPORTED SIGNIFICANT REDUCTION OF PAIN AND INCREASED QUALITY OF LIFE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below